Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.

ABSTRACT:

SUBMITTER: Stewart EA 

PROVIDER: S-EPMC7967793 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature